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The Pathogenic Mechanisms of Blister Formation in Bullous Pemphigoid 
KATSUICHI NAITO, M.D. , SHINJI MORIOKA, M.D., AND HIDEOKI OGAWA, M.D. , PH.D . 
Department of Dermatology, School of M edicin e, J untendo University, Tohyo, Japan 
Normal human skin was cultured with sera, IgG frac-
tions, and bliste r fluids (BF) from patients with bullous 
pemphigoid_ Antibody binding (IgG) was observed by 
immunofluorescence techniques at the dermal-epider-
mal junction of all skin explants cultured with sera, IgG 
fractions, and BF. Dermal-epidermal separation was ob-
served only in the skin explants cultured with BF. Der-
mal-epidermal separation was observed in 19 out of 20 
explants cultured with BF obtained from fresh bullae. In 
addition, dermal-epidermal separation can be produced 
in vivo 6 hI' after the injection of BF into the dorsal skin 
of Hartley guinea pigs. Dermal-epidermal separation 
was not observed in skin explants cultured with heat-
inactivated (56°C, 30 min) BF, although antibody binding 
was observed, In addition, dermal-epidermal separation 
did not occur when the BF w ere preincubated with rabbit 
antihuman Cl, C3, C4, and C5 antibodies. These obser-
vations suggested that both antibody and complement 
w er e essential for the production of dermal-epidermal 
separation. Since patient sera failed to produce dermal-
epidermal separation, othe r factor(s) present in BF but 
absent from serum might be n ecessary for the produc-
tion of dermal-epidermal separation. The addition of the 
proteinase inhibitors, pepstatin, EDTA, and soy bean 
trypsin inhibitor, did not inhibit the formation of dermal-
epidermal separation. In contrast, the presence of U 2-
macroglobulin inhibited dermal-epidermal separation. 
Pemphigus antibodies have been shown to induce epidermal 
acant holysis in organ cultures of normal human skin [1,2). In 
v itro experiments have suggested that acantholysis is caused by 
proteinase(s) activated by binding of pemphigus antibody 
[3-6). By contrast, pemphigoid antibodies failed to produce 
dermal-epidermal separa tion in vitro, although the pattern of 
a ntibody binding to the basement membrane zone was identical 
to t hat demonstrated by immunoelectron microscopy in skin 
lesions of bullous pemphigoid patien ts [7]. In the present study, 
organ cul ture techniques were used to investigate the in vitro 
effect on normal human skin of blister tluid from patients with 
bullous pemphigoid . 
MATERIALS AND METHODS 
Sera and Blister Fluids of Bu.llou.s Pemphigoid Patients 
Sera were obtained from 2 un treated pa tients (Cases 1 and 2) with 
bu llous pemphigoid (BP) . The titers of antibasement membrane zone 
a ntibodies (IgG ) were 1280 (Case 1) a nd 640 (Case 2). Complement-
fix ing tiLers (C3) 01' t hese a ntibodies were 16 (Case 1) and 8 (Case 2). 
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Abbreviations: 
BF: blister !luid(s) 
BP: bullous pemphigoid 
DES: dermal-epidermal separation 
DMEM: DlI lbecco's modified Eagle's medium 
EDTA: ethylenediaminetetraace tate 
PMN: polymorphonuclear 
SBT!: soybean trypsin inhibi tor 
S kin lesions of 2 patients showed depositions of immunoglobulin G 
(lgG) and C3 by direct immuno!luorescence. B lister !luids (BF) from 2 
patients were collected from newly formed blisters and pooled. As 
controls, BF from bunl patients were collected in the same manner. 
These sera and BF were stored in small aliquots at -20°C untilllsed. 
Preparation of IgO Fraction from Sera and IX2-Ma croglobulin fro m 
Citrated Plasma 
IgG fractions from pooled sera from patient.s were prepar ed by using 
p rotein A Sepharose CL 4B chromatography. T hese fTa ctions were 
then d ia lyzed against distilled water and lyophilyzed. 
H uman (x2-macroglobulin was prepar ed according to established 
methods from normal hu man citra ted plasma [8). T he purified IX2-
macroglobulin demonstrated a single arc in immunoelectrophoresis 
pla tes against anti-whole human serum a nd was quantitated by radial 
immunodiffusion (M-partigen, IX2-macroglobulin radial immunodif'fu-
ion plates, BehTing Diagnostics). 
Organ Culture Experiments 
Organ cul ture was carried out according to the method of Sarkany, 
Grice, and Caron [9). Normal human breast or abdominal skin obtained 
from surgery was s liced to abou t 0.5-ml11 thickness and cut in to ap-
proximately 2 x 2 mm pieces. T hese pieces were placed de rmis side 
down on 20 X 20 mm paTaffin-edged lens paper. T he lens paper Taft s 
were floated on 1.0 ml of culture med ium, incubated in a humid 
atmosphere containing 5% CO2 in a ir for 12, 24 , 48, and 72 hI'. The basic 
culture mediu m used was Dulbecco's modified Eagle's medium 
(DMEM) containing 60 Ilgl ml of kanamycin with no serum supplement.. 
After each cul ture period, the skin expla nts were examined by routine 
histologic (h ematoxylin and eosin staining) and immunofluorescence 
methods. All experiments were per fo rmed in triplicate. 
Dermal-Epiderm al Separation in Vitro. BP sera, BP IgG, BF from 
Case 1 or 2, and BF from bum patients as controls were added t·o t.he 
mediu m at the following concentrations: BP sera, 50%; BP IgG , 10 mgl 
ml; BF from BP or burn pat ients, 50%. 
Effects of Complement on Dennal-Epidenual Separat ion ill ' litm. 
Normal human skin was cultured in the medium containing 50% or 33Of. 
of complement- inactivated BF from BP patients. Complement- inact.i-
vated BF were prepared in two ways: (1) BF were heated at 56°C for 
30 min; a fi na l concentration of 50% BF was then used to t reat explant.s; 
(2) BF were incubated at 37°C for 30 min with equa l volumes of rabbit 
a ntiserum t.o complement components (ant i-C Is, C3 1/1" I /I""" C4 , and 
C5) and DMEM. Following centrifugation at 3000 rpm for 10 min, the 
supernatants of this preincubated mixture were used for this study as 
cul ture medium. T he fi nal concentration of BF was therefore 33%. As 
control, normal human explants were cul tured in pretreated medium 
prepared in the same manner using 1/ 3 volume BF, 1/3 volu me normal 
rabbi t serum, and 1/ 3 volume DMEM . After each culture t ime, a ll skin 
explants were exa mined by hematoxylin and eosin histology and im-
muno!luore cence. 
Effect of Proteinase Inhibitors 0 11 Dermal-Epiderm.a l Separa tion ill 
Vitro. Soybean trypsin inhibitor (SBTI) , pepstatin A, ethylenediamine-
tetraacetate (EDTA), and <¥2-macroglobulin were added to the culture 
medium containing 50% of BF with or without preincubation (37°C, 30 
min) . T his mixture was then incubated with skin explants. SBTI was 
used at fin al concent rations of 1, 2, and 5 mg/ ml in medium. Other 
inhibi tors were used at the following concentrations: pepstatin A-lO, 
20, a nd 50 Ilg/ m l; EDTA-O.Ol, 0.1, and 1.0 mM; o2-macroglobulin-l, 
4, a nd 10 mg/ ml. 
Pmductioll of Dermal-Ep iderm al Separation ill " ivo 
Male Hart ley guinea pigs were used for the study of blister formation 
ill. vivo. Approximately 0.5 ml of BF, sera, or IgG from pemphigoid 
patients was injected in traepidermaLly in to each animal, in the shaved 
skin of the back, using 6-12 separate injection sites. In addition, sera 
from pemphigoid patients preincubated with ant isera to human IgG 
were injected into the animals in the same manner. As a control , 0.5 m l 
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of 0.9% NaCI solu tion was injected similarly. Using local anesthesia 
with procaine, biopsies were taken 1, 3, 6, 12, 24, and 48 hr after t.he 
injection, from the injection sites. These skin specimens were then 
examined by histologic (hematoxylin and eosin staining) and immuno-
fluorescence methods. 
Immunofluorescence 
The anti-basement membrane zone antibody titers of sera, BF, and 
the various conditioned media were measUTed by standard indirect 
immunofluorescent techniques using normal skin as substrate. In ad-
dition, th e complement-fixing antibody titers of the preparations were 
quantitated according to Jordon, Sams, and Beutner [10]. 
After each culture time and at each postinjection time, skin explants 
or specimens were quickly frozen in liquid nitrogen, cut into 4-/lm 
sections in a cryostat, and processed for immunofluorescent staining 
according to established methods. The pattern of IgG 01' C3 deposition 
was visualized using commerciaUy available fluorescein-conjugated goat 
antihuman IgG and goat antihuman C3 (Hyland Laboratories). 
RESULTS 
Production of Dermal-Epidermal Separation in Vitro 
(Tables I, II) 
The BP antibody titers of the various preparations used are 
shown in Table 1. Antibasement membrane zone antibodies, 
C3-fIxing antibodies, and complement were present in sera, IgG 
fractions, and BF from 2 patients (Cases 1 and 2). 
Normal human skin explants were cultured for up to 3 days 
in the presence of various extracts from BP patients, i.e., sera, 
IgG fraction (antibody), and BF. There was no remarkable 
histologic change in the skin explants cultured with BP sera, 
BP IgG fraction, and control burn BF. Under the same condi-
tion, skin explants cultured with the BF -containing media, 
however, developed dermal-epidermal separations (DES) sim-
ilar to those of BP skin lesions in vivo. The DES was apparent 
by 24 hr and increased with time (Table II, Fig 1). The appear-
ance of DES was observed by 72 hr in 10 of 11 experiments, 
using BF from Case 1. In all 9 experiments using BF fi'om Case 
2, DES .appeared by 24 hr. 
Finally, DES without any acantholysis occurred in 19 out of 
20 experiments by 72 hr in the explants grown in the medium 
containing BF from BP patients (Table II) . In the presence of 
BF from bW'n patients, no DES was observed. Antibody binding 
as determined by immunofluorescence was maximal at 24 h:r 
and then dec:reased with time. A linear pattern of antibody 
binding was obse:rved at the dermal-epidermal junction. Bind-
ing of complement could not be detected in all explants. Cul-
tured explants with DES demonstrated similar linea:r deposits 
of IgG at the basement membrane zone on the epidermis side. 
Effects of Complement on Dermal·Epidermal Separation in 
Vitro (Table III) 
No :remarkable histologic fIndings were obse:rved in the E:X-
plants cultured with complement-inactivated BF. DES did not 
occu:r in those explants although the binding of anti-basement 
membrane zone antibodies could be demonst:rated in all skin 
explants. Skin explants cultured with 50% or 33% of non treated 
BF from BP patients demonstrated DES clea:rly. -
Effects of Proteinase Inhibitors on Dermal-Epidermal Sepa-
ration in Vitro (Table IV) 
Various concentrations of proteinase inhibitors (SBTI, pep-
statin A, EDT A, and lX2-mac:roglobulin) we:re added to the 
medium containing 50% of BF from BP patients. DES was not 
inhibited by pepstatin or EDT A. At the low concentrations of 
lXz-macl'oglobulin (1 and 4 mg/mI) DES was not inhibited, but 
at 10 mg/ml lX2-macroglobulin, DES was completely inhibited. 
Preincubation (37°C, 30 min) ·of lX2-macroglobulin and BF prior 
to use were more effective in inhibiting DES. Immunofluores-
cent findings have shown that the binding of pemphigoid anti-
bodies to the explants was not blocked by the proteinase 
inhibitors used. 
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TABLE 1. Immunologic findings 
TiLer of' IgG and C3- f'ixing ant.ibodies 
Bullous 
pemphigoid Serum 50% Serum" IgG 50% ElisLel' (10 mg/ml)" fluids" 
Case 1 1280 (16) /, 640 (16) 1280 (16) 320 (2) 
Case 2 640 (8) 320 (8) 320 (8) 160 (16) 
" Sera, IgG fractions, and BF from BI' patients were added to culture 
medium (DMEM) in the concentrations shown. 
/, Values in parentheses are complement-fixing (C3) titers. 
TABLE II. Histologic findings in shin explants 
Appearance of del'mal-epidel'-
Cultured with" No. of expel'i- mal separations ments 
12 hI' 24 hI' 48 hI' 72 hI' 
50% BI' sera 5 0/5 0/5 0/5 0/5 
10 mg/ml BI' IgG 5 0/5 0/5 0/5 0/5 
50% Blister fluids 20 Case 1 (11) /, 1/11 7/11 7/11 10/11 
Case 2(9)" 0/9 9/9 9/9 9/9 
50% Blister fluids 5 0/5 0/5 0/5 0/5 
from burn patients 
(control) 
"Normal skin explants were cultured in DMEM in the presence of 
sera, IgG fractions, and BF prepared from BI' patients (Cases 1 and 2). 
Blister fluids prepared from burn patients were tested as control. 
/, Number of experiments using the BF obtained from different 
blisters. 
Production of Dermal·Epidermal Separation in vivo (Table V, 
Fig 2) 
DES was observed histologically 6 hr after the injections of 
BP sera or BF into guinea pigs (Table V). Histologic findings in 
these skin specimens have shown DES and some perivascular 
cell infiltrat ions with neut:rophils, eosinophils, and some lym-
phocytes. These findings are identical to those observed in the 
skin lesions of BP patients. In addition, the injection of BP sera 
pretreated with antise:rum of human IgG did not cause DES at 
all. 
DISCUSSION 
It is well established that pemphigus antibody can induce the 
epidermal acantholysis of no:rmal skin in organ culture without 
the participation of complement [1,2]. It has been suggested 
that binding of pemphigus antibody to the epidermal cell sur-
face induces synthesis and/or activation of epithelial proteolytic 
enzymes (i.e., nonlysosomal hydrolytic enzyme (P AF) [3,5] or 
serine [4,6] and carboxyl [6] proteinase) which affect cell-to-cell 
adhesion and subsequently lead to acantholysis. 
An important role for antibody in the pathogenesis ofBP has 
been appreciated since most BP patients have serum antibodies 
reactive with specific antigen(s), and immunoglobulin and com-
plement can be detected at the dermal-epidermal junction, in 
the basal lamina and lamina lucida [11], or the basal surface of 
the basal cells [12], the ultrastructural site of DES. In contrast 
to in vitro studies showing pemphigus antibody-induced acan-
tholysis, it has been shown that BP sera failed to produce DES 
in organ cultw'e in spite of the presence of complement [7]. Ow' 
results have confirmed that neither BP sera no:r BP IgG frac-
tions produce DES in skin explants (Table lI). Immunofluores-
cence studies demonstrated the binding of BP IgG antibodies 
to the basement membrane zone of all skin specimens cultured 
with BP sera, BP IgG, and BF. Only the BF [Tom BP patients 
(which contain both anti-basement memb:rane antibodies and 
complement) produced DES in cultured explants similar to 
those in BP skin lesions in vivo (Fig 1, Table II) . A requirement 
for complement in the formation of DES was suggested since 
the formation of DES by BF was completely inhibited by 
inactivation of complement by treatment with antiserum to 
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FIG 1. Normal human skin explants were cultured with 50% blister fluids from bullous pemphigoid patient (Case 2) for 12 hr (a), 24 hI' (b), 
and 48 hI' (c ). The dermal-epidermal separations appeared at 24 Iu- without any acantholysis, and were confu'med with time. d, Normal human 
skin explants grown in DMEM at 48 hI' as control; there was no specific histologic change. X 200. 
TABLE III. Effects of complement on the derm.al·epiderm.al 
separation in uitro 
Inactivation of co mplement by 
56°C, 30 min 
Control 
(50% Blister fluids 
from BI' patient) 
Antiserum to human CI" 
Antiserum to human C3" 
Antiserum to human C4" 
Antiserum to human C5" 
Control 
(33% Blister fluids 
from BP patients) 
+ - ++ = DES, - = no DES. 
12 hI' 
Culture time 
24 hl' 48 Itr 72 hI' 
+ + ++ 
+ + + 
" Blister fluids wel'e preincubated with antiserum at 37°C for 30 min; 
after centrifugation, the supernatants were used as culture medium. 
other than antibody and complement present in BF also partic-
ipate in the production of DES. We studied the effects of 4 
proteinase inhibitors on skin expiants cultured with a 50% 
concentration of BF from BP patients (Table IV). Soybean 
trypsin inhibitor, pepstatin A, and EDTA did not inhibit the 
formation of DES; however, iX2-macrogiobulin inhibited DES. 
None of the inhibitors interfered with pemphigoid antibody 
binding to the basement membrane zone. These findings sug-
gest that neither serine proteinase nor carboxyl proteinase are 
involved in the formation of DES, and that a metalioproteinase 
such as collagenase is not necessary to produce the specific 
DES of BP. On the other hand, inhibition of DES by iX2-
macroglobulin, a universal proteinase inhibitor, suggests that 
DES might be the result of enzymatic activity. 
Our in vitro observations suggest that other factors such as 
TABLE IV. Effects of proteinase inhibitors on derm.al·epidermal 
separations in vitro 
Proteinnse inhibitors (final concentru· Cul ture time 
tion) 24 hI' 48 hr 72 hI' 
Control a" + ++ 
(50% Blister fluids) b " + ++ 
Soybean trypsin inhibitor a + ++ 
5 mg/ ml b + ++ 
I'epstatin A a + ++ 
5!-Lg/ ml b + ++ 
EDTA a + ++ 
1mM b + ++ 
a . -Macroglobulin a + ++ 
1 mg/ ml b + ++ 
a ± + 
4 mg/ ml b + + 
10 mg/ ml a + 
b 
+ - ++ = DES, - = no DES. 
n Proteinase inhibi tors were added to the culture medium containing 
50% BF with (b) or without (a) preincubation (37 °C, 30 min). There-
after, normal human skin explants were cultured using those cul tme 
media. 
enzymes are important for the formation of DES. We postulate 
t hat following antigen-antibody binding, complement fixation 
and production of chemotactic factors result in the influx of 
inflammatory cells such as polymorphonuclear (PMN) leuko-
cytes into the skin. Other factors sllch as proteinase might then 
be secreted by the inflammatory cells producing :qES; and BP 
BF, the reaction products, aheady contain the effective factors 
(such as proteinase) besides antibody and complements. Fol-
lowed antigen-antibody binding, complement fixation resulted 
in conformational. changes on antigenic sites; the factors such 
as proteinase might then digest these modified portions. Gam-
mon et a.l [13] reported that complement-fixing pemphigoid 
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TABLE V. Dermal·epidermal separations in vivo (Hartley 
guinea pig) 
Time afte r the intraepide l"mal injection 
1 h1" 3 hr 6 hI" 12 hr 24 Ill' 48 h I" 
BP blister fluid ± + + + + 
BP serum ± + + + + 
BP serum + anti-IgG 
Control (0.9% NaC!) 
+ - ++ = DES, - "= no DES. 
FIG 2. Dermal-epidermal separations (DES) could be produced in 
vivo 6 hr after the injection of bullous pemphiboid (BP) sera. DES and 
some perivascular cell infiltrations with neutrophils, eosinophils, and 
some lymphocytes, identical to the skin lesions of BP patients in. vivo, 
were seen. X 320. 
antibodies can mediate specific leukocy te attachment to the 
dermal-epiderm al junction in vitro and that the leukocyte 
attachment requires complement. Histologic observation of skin 
expla nts· showed inflammatory PMN leukocytes close to the 
dermal-epidermal junction in th e early stage of blister form a-
tion (Fig 2). Therefore there may be two possible roles of 
complement in BP: one is the che motactic factors for PMN 
leukocytes and the other the modification fac tors for enzymatic 
digestion. In in vitro studies using organ culture, complem ents 
in BF are still required as th e modification factors on antige nic 
sites. In vivo studies using BP sera c1eaJ'ly resulted in DES. 
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When BP sera a re injected intraepiderma Uy into t h e animals 
following a ntigen-antibody binding, comple ment fixation a nd 
production of chemotactic factors result in the influx of PMN 
leukocytes into the skin and some conformational changes on 
antigenic sites . Then the factors such as proteinase fTom PMN 
leukocytes might diges t these antigenic s ites, resulting in t h e 
specific dermal-epidermal separation . 
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